Sensyne Health is an Oxford, UK-based healthcare technology company, specialised in clinical artificial intelligence.



  • Company is led by Lord Paul Drayson, former UK Science Minister
  • Speeds up the discovery of new medicines and improves patient care by developing new digital health tools
  • Listed on AIM in August 2018 and raised £60m in an IPO, with a post float valuation of c.£225m



  • Maximise company profile and establish credibility with key stakeholders and media throughout the IPO process
  • Help to educate the market on the clinical artificial intelligence opportunity from pre-IPO
  • Refine key messages and equity story for the wider financial community, ensuring these are reflected across all materials



  • Sensyne Health successfully started trading on AIM on 17 August 2018
  • Extensive media coverage appeared across international business, local, trade and investment media
  • Consilium has continued to act as an adviser to the publicly listed company
  • Share tips have been placed in national newspapers since IPO to drive demand and support the shares